SOURCE: Xtalks

Xtalks Webinars

October 27, 2016 08:33 ET

Biopharma Deal Making: Lessons Learnt from Cass Business School's Study of Strategic Deals and Corporate Portfolio Management, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - October 27, 2016) - During a live broadcast on Tuesday, November 15, 2016 industry expert Guy Henninger, Senior Life Sciences Executive at Intralinks will outline the key findings from the research and undercover the strategies of the excellent corporate portfolio managers who consistently outperform the market.

Extensive prior studies have shown strong positive effects for targets and negative effects for acquirers but, they've have focused on measuring value creation from individual deals, not a firm's overall programs of activity and performance over longer time periods. This far reaching study analyzed over 20 years of data from 25,000+ global firms and 265,000+ deals.

For more information or to register for this complimentary event, visit: Biopharma Deal Making: Lessons Learnt from Cass Business School's Study of Strategic Deals and Corporate Portfolio Management

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, to private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/10/27/11G119743/Images/Intralinks_CMYK_v1-d3182b6959a3b4afb93632a859f42aff.jpg

Contact Information